Meireles, Pedro AntunesBessa, FilipeGaspar, PedroParreira, InêsSilva, Virgílio DiasMota, CatarinaAlvoeiro, Lourdes2021-03-172021-03-172020EJCRIM 2020; Vol 7, No 62284-2594http://hdl.handle.net/10451/46880© EFIM 2020. This article is licensed under a Commons Attribution Non-Commercial 4.0 License.Coronavirus disease 2019 (COVID-19) is a multisystemic condition caused by severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) with manifestations ranging from mild upper respiratory symptoms to cytokine storm causing acute respiratory distress syndrome. Pancreatic exocrine tissue and endocrine islets both express angiotensin-converting enzyme 2 (ACE2), the proven receptor for SARSCoV-2 cell internalization. An increase in pancreatic enzymes has been increasingly recognized in patients with COVID-19, but little is known about the real prevalence of acute pancreatitis in this population. We report a case of acute acalculous pancreatitis in a COVID-19 patient.engSARS-CoV-2COVID-19AmylaseLipaseAcute pancreatitisjournal article10.12890/2020_001710